S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 83 200 KRW -2.92% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Receivables
â‚©122.6B
CAGR 3-Years
39%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Total Receivables
â‚©1T
CAGR 3-Years
40%
CAGR 5-Years
60%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Total Receivables
â‚©6.6B
CAGR 3-Years
-9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Receivables
â‚©3.6B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Receivables
â‚©20.9B
CAGR 3-Years
-32%
CAGR 5-Years
-20%
CAGR 10-Years
80%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Receivables
â‚©1.8B
CAGR 3-Years
68%
CAGR 5-Years
35%
CAGR 10-Years
N/A
No Stocks Found

ST Pharm Co Ltd
Glance View

Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
97 768.06 KRW
Undervaluation 15%
Intrinsic Value
Price
S

See Also

What is ST Pharm Co Ltd's Total Receivables?
Total Receivables
122.6B KRW

Based on the financial report for Sep 30, 2024, ST Pharm Co Ltd's Total Receivables amounts to 122.6B KRW.

What is ST Pharm Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
47%

Over the last year, the Total Receivables growth was 111%. The average annual Total Receivables growth rates for ST Pharm Co Ltd have been 39% over the past three years , 47% over the past five years .

Back to Top